What is DIMESNA used for?

DIMESNA is being studied for its potential use in treating non-small cell lung carcinoma and lung adenocarcinoma.

Is DIMESNA approved for lung cancer?

DIMESNA is currently in Phase 3 clinical trials, meaning it is still being tested and is not yet a standard approved treatment.

What kind of drug is DIMESNA?

DIMESNA is classified as a small molecule drug.

Can I take DIMESNA orally?

Information regarding whether DIMESNA is taken by mouth is currently unavailable in the provided data.

Is DIMESNA a natural product?

No, DIMESNA is not a natural product.

Are there known side effects for DIMESNA?

There are no specific side effects listed in the current research summary provided.

Dimesna | CAS 16208-51-8 | KQYGMURBTJPBPQ

Loading compound...

Small molecule

DIMESNA is a small molecule drug currently being studied in clinical trials. Research indicates it may be used in the treatment of certain types of lung cancer, such as non-small cell lung carcinoma and lung adenocarcinoma.

Used for

non-small cell lung carcinomalung adenocarcinoma

Conditions

non-small cell lung carcinomalung adenocarcinoma

Class

Small molecule

How to take

DIMESNA is currently in the research phase (Phase 3) and is not yet widely available for general use.

Talk to your doctor

Questions to ask

·Is DIMESNA appropriate for my specific type of lung cancer?
·What stage of clinical trials is DIMESNA currently in?
·Are there any known interactions between DIMESNA and my current medications?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)